Appelbaum Kevin J Insider Trades

Insider Trading History

Track insider trading activity for Appelbaum Kevin J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Better Therapeutics
Better Therapeutics MCAD
10% owner, Chief Executive Officer
Holding Value $39.1k 3,750 shares
Last Trade
Dec 20, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.4k 1,000 shares
$10.43
$10.43
Better Therapeutics
Better Therapeutics BTTX
10% owner, Chief Executive Officer
Holding Value $0.375 3,750 shares
Last Trade
Dec 20, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.6k 1,000 shares
$4.60
$0.00
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
10% owner, Chief Executive Officer
Holding Value $3.86k 3,750 shares
Last Trade
Dec 20, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.03k 1,000 shares
$1.03
$1.03
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
10% owner, Chief Executive Officer
Holding Value $43.3k 3,750 shares
Last Trade
Dec 20, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.5k 1,000 shares
$11.54
$11.54
Better Therapeutics
Better Therapeutics BTTX
10% owner, Chief Executive Officer
Holding Value $0.275 2,750 shares
Last Trade
Dec 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.53k 750 shares
$4.71
$0.00
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
10% owner, Chief Executive Officer
Holding Value $2.83k 2,750 shares
Last Trade
Dec 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$773 750 shares
$1.03
$1.03
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
10% owner, Chief Executive Officer
Holding Value $31.7k 2,750 shares
Last Trade
Dec 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.66k 750 shares
$11.54
$11.54
Better Therapeutics
Better Therapeutics MCAD
10% owner, Chief Executive Officer
Holding Value $28.7k 2,750 shares
Last Trade
Dec 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.82k 750 shares
$10.43
$10.43
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
10% owner, Chief Executive Officer
Holding Value $23.1k 2,000 shares
Last Trade
Dec 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.5k 1,000 shares
$11.54
$11.54
Better Therapeutics
Better Therapeutics BTTX
10% owner, Chief Executive Officer
Holding Value $0.2 2,000 shares
Last Trade
Dec 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.98k 1,000 shares
$5.98
$0.00
Better Therapeutics
Better Therapeutics MCAD
10% owner, Chief Executive Officer
Holding Value $20.9k 2,000 shares
Last Trade
Dec 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.4k 1,000 shares
$10.43
$10.43
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
10% owner, Chief Executive Officer
Holding Value $2.06k 2,000 shares
Last Trade
Dec 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.03k 1,000 shares
$1.03
$1.03
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
10% owner, Chief Executive Officer
Holding Value $11.5k 1,000 shares
Last Trade
Dec 03, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.77k 500 shares
$11.54
$11.54
Better Therapeutics
Better Therapeutics MCAD
10% owner, Chief Executive Officer
Holding Value $10.4k 1,000 shares
Last Trade
Dec 03, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.22k 500 shares
$10.43
$10.43
Better Therapeutics
Better Therapeutics BTTX
10% owner, Chief Executive Officer
Holding Value $0.1 1,000 shares
Last Trade
Dec 03, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.22k 500 shares
$6.43
$0.00
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
10% owner, Chief Executive Officer
Holding Value $1.03k 1,000 shares
Last Trade
Dec 03, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$515 500 shares
$1.03
$1.03
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
10% owner, Chief Executive Officer
Holding Value $5.77k 500 shares
Last Trade
Dec 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.77k 500 shares
$11.54
$11.54
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
10% owner, Chief Executive Officer
Holding Value $515 500 shares
Last Trade
Dec 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$515 500 shares
$1.03
$1.03
Better Therapeutics
Better Therapeutics MCAD
10% owner, Chief Executive Officer
Holding Value $5.22k 500 shares
Last Trade
Dec 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.22k 500 shares
$10.43
$10.43
Better Therapeutics
Better Therapeutics BTTX
10% owner, Chief Executive Officer
Holding Value $0.05 500 shares
Last Trade
Dec 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.42k 500 shares
$6.84
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up